Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tristel is a global leader in infection prevention and contamination control, specializing in the development and manufacture of high-level disinfection products. The company's core technology is a proprietary chlorine dioxide (ClO2) formulation used to rapidly disinfect medical instruments and hospital surfaces. Tristel's product portfolio includes specialized solutions for ultrasound probes, endoscopes, and various clinical environments such as ENT, cardiology, and ophthalmology. Publicly traded on the London Stock Exchange, the company serves healthcare providers worldwide to mitigate the risk of healthcare-associated infections and ensure patient safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tristel Solutions.